Business Context and Reporting Period
Company: NETWORK-1 TECHNOLOGIES, INC. (NTIP)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2026
Business Model: The Company is an intellectual property holding company focused on the development, licensing, and protection of patent portfolios. Key portfolios include M2M/IoT (eSIM technology), High Frequency Trading (HFT), Cox (media content identification), and Smart Home technologies. The Company also holds an equity investment in ILiAD Biotechnologies, Inc.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Revenue | $0 | $150,000 |
| Operating Expenses | $2,428,000 | $1,515,000 |
| Operating Loss | $(2,428,000) | $(1,365,000) |
| Net Loss | $(1,166,000) | $(826,000) |
| Net Loss Per Share (Basic/Diluted) | $(0.05) | $(0.04) |
| Cash and Cash Equivalents | $9,435,000 | $13,424,000 |
| Marketable Securities | $24,317,000 | $23,467,000 |
| Total Assets | $38,466,000 | $40,332,000 |
| Working Capital | $33,179,000 | $36,336,000 |
| Long-Term Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Revenue dropped to $0 for the six months ended June 30, 2026, compared to $150,000 in the prior year period, due to a lack of litigation settlements or licensing agreements.
- Increased Operating Expenses: Operating expenses rose by $913,000 (60%) to $2.43 million, primarily driven by a $962,000 increase in litigation-related professional fees.
- Equity Investment Gain: The Company recorded a non-cash gain of $1,052,000 on its equity investment in ILiAD Biotechnologies. This resulted from ILiAD's Series B financing in February 2026, which triggered a change in accounting from the equity method to the cost method.
- Investment Losses: The Company recorded a net realized and unrealized loss of $279,000 on marketable securities, compared to a gain of $171,000 in the prior year, attributed to rising interest rates affecting fixed-income securities.
- Cash Flow: Net cash used in operating activities increased to $1.24 million from $502,000 in the prior year. Net cash used in investing activities was $1.44 million, a shift from $2.15 million provided by investing activities in 2025, due to net purchases of marketable securities and patent acquisitions.
Guidance, Outlook, and Risks
- Outlook: Future revenue is entirely dependent on the monetization of patent portfolios (M2M/IoT, HFT, Cox, Smart Home) and the outcome of pending litigation. Management anticipates continuing semi-annual cash dividends of $0.05 per share, subject to Board review.
- Legal Proceedings:
- Google/YouTube: The Federal Circuit overturned a lower court's non-infringement judgment regarding Patent No. 8,205,237 (Content ID) in April 2026. The case was remanded for further proceedings with a trial scheduled for December 7, 2026.
- Samsung: Litigation regarding eSIM/5G patents continues. The PTAB denied Samsung's requests for Inter Partes Review (IPR) on all six asserted patents in April and May 2026.
- HFT Litigation: Active cases against Optiver and Citadel Securities. The case against Jump Trading was dismissed without prejudice in July 2026.
- Risks:
- Personal Holding Company (PHC) Status: The Company faces the risk of being classified as a PHC in 2026, which could trigger a 20% tax on undistributed income, potentially requiring a special cash dividend.
- Litigation Uncertainty: Outcomes of pending lawsuits are uncertain and could materially impact financial results.
- ILiAD Investment: The Company no longer has board representation at ILiAD following its financing, and the investment is now accounted for at cost, limiting visibility into ILiAD's operational performance.
Investor Verification Checklist
- Dividend Sustainability: Verify if the Company's cash burn rate ($1.24M operating cash outflow in 6 months) and lack of operating revenue threaten the continuation of the $0.05 semi-annual dividend policy.
- Google Litigation Remand: Monitor the December 2026 trial date for the Google/YouTube case to assess the probability of a settlement or judgment following the Federal Circuit's favorable ruling.
- PHC Tax Exposure: Confirm shareholder ownership concentration to determine if the Company meets the "Ownership Test" for Personal Holding Company status, which would impact net cash available for operations.
- Patent Portfolio Monetization: Review the status of the HFT and M2M/IoT portfolios, as these represent the primary remaining sources of potential future revenue.
- Share Repurchase Program: Note that $4.78 million remains available under the current repurchase program, which may be utilized to support share price or return capital.